If a patient has a BMI over 30, or over 27 with at least one weight-related health condition, some insurers will approve coverage after a prior authorization process that documents the medical necessity and failed attempts with other therapies, says Suzanne Manzi, MD, a board-certified obesity medicine, pain medicine, rehabilitation, and electrodiagnostic medicine physician and co-founder of Performance Pain and Sports Medicine in Houston, Texas
References Bowers, C
(2025) Disproportionality analysis of GLP-1 receptor agonists combined with metformin based on the FAERS database.Sci Rep 15, 2.Xie Z, Hu J, Gu H, Li M and Chen J (2023) Comparison of the efficacy and safety of 10 glucagon-like peptide-1 receptor agonists as add-on to metformin in patients with type 2 diabetes: a systematic review.Front
Has Melanotan I been studied in humans
is a Board-Certified Neurologist and offers customized peptide therapy programs for sexual health, athletic performance and sport injuries
.png)
